FDA Inspection 1203279 — Brigham And Women's Hospital, Inc., The
The FDA completed an inspection of Brigham And Women's Hospital, Inc., The on Apr 11, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boston, MA (United States)